All notes

3 min readFundraising

Healthtech seed pitches: pilots and buyers

How health tech founders can explain pilot results, purchasing decisions, deployment costs and the next milestone in a seed fundraising pitch.

By Variance Ventures

“We have three pilots” can describe three paid evaluations with decision dates, three informal demonstrations, or three projects waiting for access to customer systems. A healthtech seed investor needs to understand which situation applies before interpreting the number.

A useful fundraising pitch follows the evidence from the original workflow through evaluation and toward a purchasing decision. It explains what a pilot proved, what remains unresolved, and how the next round pays for the work between them.

Define the pilot before reporting its results

Start with the customer, use case, scope, duration, and commercial arrangement. State whether the product is used in an operational setting, tested with historical information, or demonstrated without a live integration.

Describe who agreed to participate and who can authorize a purchase. Where you cannot name an organization publicly, give enough context to explain the deployment without exposing confidential information.

An illustrative administrative software pilot might examine how a clinic handles follow-up tasks. The relevant evidence could include task completion, implementation effort, staff adoption, and the handling of exceptions. That is different from evidence about patient health outcomes; operational observations should not be presented as clinical proof.

Agree on what success would mean

A pilot becomes more informative when the parties understand the decision it is intended to support. Is the customer testing technical feasibility, user acceptance, a business case, or readiness for a paid rollout?

For each question, explain the baseline and how the comparison was made. If a founder manually completed part of the workflow, include that effort in the results. If only a narrow group of enthusiastic users participated, explain the limits on generalizing their behavior.

Measures should fit the use case. A reduction in time spent on one task might matter, but an investor also needs to know whether that time can be used productively and whether implementation creates work elsewhere. A simple before-and-after chart does not resolve those questions by itself.

Map the route from champion to budget

Make the buying process visible. Identify the product champion, end users, technical reviewers, budget owner, and procurement decision. Show where security, legal, clinical, or other specialist review sits when relevant to the deployment.

Distinguish a favorable user interview from an approved budget. For each opportunity in the pipeline, record the completed step, next decision, responsible person, and expected timing. Label an estimated decision date as an estimate.

This provides a better view of commercial progress than combining exploratory meetings, unpaid evaluations, and signed contracts into one headline pipeline number.

Account for the cost of serving the customer

Early health tech deployments can involve substantial work outside product engineering. Explain integration, configuration, onboarding, ongoing support, and any clinical or operational staffing needed to deliver the service.

If the business is software, separate recurring product revenue from services and implementation charges. If it delivers care or relies on third-party providers, make those delivery costs visible. If reimbursement is material to the model, show what is established and which assumptions remain untested.

A founder should be able to explain what gets easier on the second deployment. Which integration or procedure can be reused, and which work starts again for every customer? That is often an important question for a seed round intended to move beyond the first pilot.

Build the financing story around the next decision

Rather than promising a fixed number of pilots, connect the round to evidence the company needs. Examples might include completing a defined evaluation, securing a funded expansion, reducing onboarding effort, or demonstrating that an additional customer can deploy the product under comparable conditions.

Include the expected sales cycle and a delay case. Health tech financing plans become fragile when they assume every customer signs on the founder’s preferred timeline. Describe which work can continue while purchasing decisions remain open.

Choose investors who fit the route to market

Use our health tech investor guide to compare firms, and read our health tech investment focus alongside the broader six-sector overview.

Variance Ventures considers seed and pre-seed companies primarily in the US and globally, with flexible initial checks typically around $50,000. If your company fits, send a pitch that connects the product, pilot evidence, purchasing path, and capital requirements. Clear definitions help the conversation start with the business you are actually building.